ABMD

Q: What is the price of Abiomed (ABMD) today?

The price of Abiomed (ABMD) today is $ 0.00, with return of 0% compared to the last year. The price of Abiomed (ABMD) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Abiomed (ABMD) and international markets.

Q: When does Abiomed (ABMD) pay dividends?

Abiomed (ABMD) did not distribute dividends in the last year.

Q: Is Abiomed (ABMD) worth it?

Currently, Abiomed (ABMD) is priced at $ 0.00, with a P/E of 64.27%, representing a deviation of 6,427% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Abiomed (ABMD) stock?

Investing in stocks of Abiomed (ABMD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Abiomed (ABMD) yield today?

The yield of Abiomed (ABMD) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Abiomed (ABMD) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Abiomed Inc.

Price

$ -

return (12m)

0.00%

p/e

64.27

p/bv

11.14

DIVIDEND YIELD

0.00%

ABMD price

ABMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ABMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ABMD

review the fundamentals of Abiomed shares

P/E

64.27

Sector: -2.04 Industry: -5.48

P/S (PSR)

15.96

Sector: 1.88 Industry: 2.88

P/BV

11.14

Sector: 2.11 Industry: 2.07

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

15.72%

Sector: -25.47% Industry: -47.59%

ROE

17.32%

Sector: -29.41% Industry: -43.15%

ROIC

22.11%

Sector: -411.21% Industry: -461.26%

NET MARGIN

24.84%

Sector: -28.27% Industry: -33.57%

GROSS MARGIN

81.32%

Sector: 44.66% Industry: 45.25%

OPERATING MARGIN

23.66%

Sector: -23.29% Industry: -29.30%

EV/EBITDA

60.87

Sector: -0.79 Industry: -3.70

EV/EBIT

67.48

Sector: -2.18 Industry: -5.34

PRICE-TO-ASSETS

10.11

Sector: 1.13 Industry: 1.26

BVPS

34.22

Sector: 3.60 Industry: 1.97

EPS

5.93

Sector: -0.89 Industry: -1.31

EQUITY-TO-ASSETS RATIO

0.91

Sector: 0.43 Industry: 0.47

LIABILITIES / ASSETS

0.91

Sector: 0.47 Industry: 0.42

CAGR REVENUE 5 YEARS

1.38%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

14.93%

Sector: - Industry: -

FAIR VALUE OF Abiomed ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ABMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ABMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Abiomed

Abiomed Inc.

Average Investor10 user rating

4.0 (7 people)

United States

39 years

Founded: 1987

1987

Time since IPO - 39 years

1.536

Employees

The Company Abiomed Inc. (United States), is listed on Nasdaq with a market value of $ 17.15 Billions, having an equity of $ 1.54 Billion.

With a total of 1.536 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 1.07 Billion, which generated a profit in the amount of $ 266.76 Millions.

As for its main indicators, the Company has a P/E ratio of 64.27, a P/BV ratio of 11.14 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ABMD.

Market cap

$ 17.15 Billions

Net worth

$ 1.54 Billion

US$ 1,539,790,000.00

Assets

$ 1.70 Billion

US$ 1,696,540,000.00

Total Shares Outstanding

45.00 Millions

45,000,000

Average Daily Trading Volume

$ 1.73 Million

US$ 1,728,521.32

Sector

Health

Industry

Medical Supplies and Equipment

ABMD

ABMD revenue and profits

Financial Results ABMD

DRAG THE FRAME TO SEE MORE DATA

ABMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 71.82 10,73% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 266.75 --17,71% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 32.74 --45,84% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 173.39 --33,25% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 473.24 37,82% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 919.77 13,23% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 152.75 47,20% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10